In the news

Beactica’s drug discovery platform delivers promise for brain tumour therapy

Article in SciTech Europa Quarterly 27, 2018

Beactica's CEO, Dr Per Källblad, explains how the company’s specialist small molecule drug discovery platform is developing a novel therapy for glioblastoma. 

Read full article here.

SciTech Europa Quarterly 28 - Beactica - Fig